Xarelto Cases Consolidated in New Orleans
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The most important recent news is that a federal panel of judges has granted the request of The Michael Brady Lynch Firm and others to centralize pending and subsequent Xarelto lawsuits. The judge will centralize these Xarelto case in the U.S.
Read MoreFDA Revises Cancer Warning and Use Indications for Morcellators
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The FDA has now weighed in on the use of morcellators for the removal of fibroid in women. Simply put, the warning are frightening. The “vast majority” of women getting fibroids removed should not be treated using devices called morcellators, which
Read MoreJury Finds Actos Manufacturer Intentionally Destroyed Evidence
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. This is truly deplorable conduct on behalf off the manufacturer of Actos. Takeda Pharmaceutical Co. was ordered by a jury to pay $155,000 over its destruction of documents about its Actos diabetes medicine after the panel concluded the missing files blocked
Read MoreLevaquin Linked to Irreversible Peripheral Neuropathy
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. There are new concerns over the popular drug Levaquin (levofloxacin), which is is an antibiotic medication linked to severe and sometimes permanent nerve damage. Levaquin (levofloxacin) is an antibiotic medication that has been linked to a condition known as peripheral neuropathy (nerve
Read MoreXarelto Petition Filed Requesting Consolidation in Illinois
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. A Xarelto MDL is likely on the very near on the horizon. As a growing number of Xarelto lawsuits continue to be filed in U.S. District Courts nationwide, a group of plaintiff attorneys, including attorney Michael Brady Lynch, Esq., of The
Read MoreFDA Panel Recommends Label Change for Low T Usage
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. There could be major changes ahead in the prescribing recommendations for drugs that treat low testosterone. A blue-ribbon expert panel voted overwhelmingly on Wednesday for the Food and Drug Administration to impose strict new limitations on the multibillion-dollar testosterone drug industry,
Read MorePropecia Lawsuit Concerns Continue to Rise
This is Propecia attorney Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Every day the role of Merck in the public health disaster involving Propecia continues to raise grave concerns over the character and morality of Merck, one of the world’s largest pharmaceutical conglomerates. It is vitally important to note in
Read MorePower Morcellation Devices Linked to Cancer
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. FDA discourages use of laparoscopic power morcellation for removal of uterus or uterine fibroids. In a safety communication notice, the U.S. Food and Drug Administration discouraged the use of laparoscopic power morcellation for the removal of the uterus (hysterectomy) or uterine fibroids
Read MoreConsumer Alert! Viagra Link to Skin Cancer
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. A new study shows a possible link between popular erectile dysfunction drugs and an increased risk of developing a deadly form of skin cancer. The disturbing link comes from a large study in JAMA Internal Medicine that followed nearly 26,000 men who had
Read MoreTestosterone Supplements Linked to Life Threatening Cardiac Events
The latest data is out on the correlation between treatments for so-called “Low T” and cardiac events such as heart, attack, stroke and pulmonary embolism, and the results are truly frightening. The most recent study was funded by the National Institutes of Health and published in the journal of PLOS ONE. The study evaluated over 55,000
Read More